{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:46:22Z","timestamp":1791276382524,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2000,10]]},"DOI":"10.1006\/rtph.2000.1421","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T17:19:16Z","timestamp":1032369556000},"page":"210-218","source":"Crossref","is-referenced-by-count":90,"title":["Pharmaceutical Excipient Development: The Need for Preclinical Guidance"],"prefix":"10.1006","volume":"32","author":[{"given":"Paul","family":"Baldrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/rtph.2000.1421_RF1","series-title":"Compendium of Data Sheets and Summaries of Product Characteristics 1998\u201399","year":"1998"},{"key":"10.1006\/rtph.2000.1421_RF2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/019262338601400113","article-title":"A review of unique male rat hydrocarbon nephropathy","volume":"14","author":"Alden","year":"1986","journal-title":"Toxicol. Pathol."},{"key":"10.1006\/rtph.2000.1421_RF3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1177\/096032719501400903","article-title":"An overview of the toxicology of HFA-134a (1,1,1,2-tetrafluoroethane)","volume":"14","author":"Alexander","year":"1995","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1006\/rtph.2000.1421_RF4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1542\/peds.99.2.268","volume":"99","year":"1997","journal-title":"Pediatrics"},{"key":"10.1006\/rtph.2000.1421_RF5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0278-6915(97)00041-0","article-title":"A toxicological review of lactose to support clinical administration by inhalation","volume":"35","author":"Baldrick","year":"1997","journal-title":"Food Chem. Toxicol."},{"key":"10.1006\/rtph.2000.1421_RF6","series-title":"Encyclopedia of Pharmaceutical Technology","first-page":"289","article-title":"Pharmaceutical excipient testing\u2014A regulatory and preclinical perspective","author":"Baldrick","year":"2000"},{"key":"10.1006\/rtph.2000.1421_RF7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/10915818809078703","article-title":"Sugars and adrenomedullary proliferative lesions: The effects of lactose and various polyalcohols","volume":"7","author":"B\u00e4r","year":"1988","journal-title":"J. Am. Coll. Tox."},{"key":"10.1006\/rtph.2000.1421_RF8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/10915819209141498","article-title":"Significance of Leydig cell neoplasia in rats fed lactitol or lactose","volume":"11","author":"B\u00e4r","year":"1992","journal-title":"J. Am. Coll. Tox."},{"key":"10.1006\/rtph.2000.1421_RF9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF02771765","article-title":"Place of excipients in drug-related allergy","volume":"13","author":"Barband","year":"1995","journal-title":"Clin. Rev. Allergy Immun."},{"key":"10.1006\/rtph.2000.1421_RF10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/109158199225684","article-title":"An evaluation of genotoxicity tests with Aquateric aqueous enteric coating","volume":"18","author":"Batt","year":"1999","journal-title":"Int. J. Toxicol."},{"key":"10.1006\/rtph.2000.1421_RF11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0091-6749(98)70186-1","article-title":"Evaluation of a non-chlorofluorocarbon formulation of cromolyn sodium (Intal) metered-dose inhaler versus the chlorofluorocarbon formulation in the treatment of adult patients with asthma: a controlled trial","volume":"101","author":"Blumenthal","year":"1998","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1006\/rtph.2000.1421_RF12","series-title":"Guidance for Industry: Guidelines for the Format and Content of the Nonclinical Pharmacology\/Toxicology Section of an Application","year":"1987"},{"key":"10.1006\/rtph.2000.1421_RF13","first-page":"1523","article-title":"Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation","volume":"41","author":"Cheng","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1006\/rtph.2000.1421_RF14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/03602539808996317","article-title":"Cell proliferation and carcinogenesis","volume":"30","author":"Cohen","year":"1998","journal-title":"Drug Metab. Rev."},{"key":"10.1006\/rtph.2000.1421_RF15","unstructured":"CPMP\/DGIII, 1992, CPMP\/DGIII Guideline III\/3038\/91, Note for Guidance: EC application Format, adopted March 1992. Commission of the European Communities, Brussels."},{"key":"10.1006\/rtph.2000.1421_RF16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1006\/rtph.1997.1099","article-title":"Considerations for toxicology studies of respiratory drug products","volume":"25","author":"De George","year":"1997","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1006\/rtph.2000.1421_RF17","first-page":"11","article-title":"The safety of pharmaceutical excipients","volume":"54","author":"de Jong","year":"1999","journal-title":"Th\u00e9rapie"},{"key":"10.1006\/rtph.2000.1421_RF18","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1023\/A:1015921101465","article-title":"Absorption of polyethylene glycols 600 through 2000: The molecular weight dependence of gastrointestinal and nasal absorption","volume":"7","author":"Donovan","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1006\/rtph.2000.1421_RF19","series-title":"Inactive Ingredients Guide","year":"1996"},{"key":"10.1006\/rtph.2000.1421_RF20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0273-2300(91)90042-T","article-title":"The human relevance of the renal tumor-inducing potential of d-limonene in male rats: Implications for risk assessment","volume":"13","author":"Flamm","year":"1991","journal-title":"Regul. Tox. Pharm."},{"key":"10.1006\/rtph.2000.1421_RF21","first-page":"433","article-title":"The parthogenesis of reticulo-endothelial foam cells: Effect of polyvinylpyrrolidone on the liver of the mouse","volume":"32","author":"Frommer","year":"1956","journal-title":"Am. J. Pathol."},{"key":"10.1006\/rtph.2000.1421_RF22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF03259883","article-title":"Pharmaceutical excipients: Adverse effects associated with \u2018inactive\u2019 ingredients in drug products (Part II)","volume":"3","author":"Golightly","year":"1988","journal-title":"Med. Toxicol."},{"key":"10.1006\/rtph.2000.1421_RF23","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/rtph.1995.1036","article-title":"An analysis of the National Toxicology Program's (NTP) Technical Report (NTP TR 421) on the toxicology and carcinogenesis studies of talc","volume":"21","author":"Goodman","year":"1995","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1006\/rtph.2000.1421_RF24","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/S0264-410X(97)00116-3","article-title":"Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers","volume":"15","author":"Gupta","year":"1997","journal-title":"Vaccine"},{"key":"10.1006\/rtph.2000.1421_RF25","first-page":"111","article-title":"Teratogenic evluation of alternative vehicles: PEG 400, cremophor, carboxy-methylcellulose\u2014Comparisons with methylcellulose","volume":"53","author":"Gupta","year":"1996","journal-title":"Teratology"},{"key":"10.1006\/rtph.2000.1421_RF26","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.2042-7158.1996.tb05980.x","article-title":"Twenty-eight-day double-blind safety study of an HFA-134a inhalation aerosol system in healthy subjects","volume":"48","author":"Harrison","year":"1996","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1006\/rtph.2000.1421_RF27","series-title":"European Pharmaceutical Contractor (epc)","article-title":"Novel excipients for sugar-free preparations\u2014Functionality and performance","author":"Herbert","year":"1998"},{"key":"10.1006\/rtph.2000.1421_RF28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1211\/0022357991772565","article-title":"Single- and repeated-dose local toxicity in the nasal cavity of rabbits after intranasal administration of different glycols for formulations containing benzodiazepines","volume":"51","author":"Hjortkjaer","year":"1999","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1006\/rtph.2000.1421_RF29","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1023\/A:1011929016601","article-title":"Chitosan and its use as a pharmaceutical excipient","volume":"15","author":"Illum","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1006\/rtph.2000.1421_RF30","first-page":"657","article-title":"Transferrin conjugated PEG-liposomes as intracellular targeting carrier for tumor therapy","volume":"56","author":"Ishida","year":"1998","journal-title":"Nippon Rinsho"},{"key":"10.1006\/rtph.2000.1421_RF31","series-title":"Japanese Pharmaceutical Excipients Directory","year":"1996"},{"key":"10.1006\/rtph.2000.1421_RF32","unstructured":"Japanese Technical Requirements for New Drug Registration, 1997, Yakuji Nippon Ltd. Tokyo."},{"key":"10.1006\/rtph.2000.1421_RF33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(99)00176-3","article-title":"Studies of beneficial interactions between active medicaments and excipients in pharmaceutical formulations","volume":"187","author":"Kalinkova","year":"1999","journal-title":"Int. J. Pharmacol."},{"key":"10.1006\/rtph.2000.1421_RF34","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1021\/js980080t","article-title":"Multivesicular liposome (DepoFoam) technology for the sustained delivery of Insulin-like Growth Factor-I (IGF-I)","volume":"87","author":"Katre","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1006\/rtph.2000.1421_RF35","series-title":"Handbook of Pharmaceutical Excipients","author":"Kibbe","year":"2000"},{"key":"10.1006\/rtph.2000.1421_RF36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/109158199225675","article-title":"Subchronic toxicity and development toxicity studies in rats with Aquateric aqueous enteric coating","volume":"18","author":"Kotkoskie","year":"1999","journal-title":"Int. J. Toxicol."},{"key":"10.1006\/rtph.2000.1421_RF37","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0041-008X(89)90007-0","article-title":"d-Limonene-induced male rat-specific nephrotoxicity: Evaluation of the association between d-limonene and \u03b12\u03bc-globulin","volume":"99","author":"Lehman-McKeeman","year":"1989","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1006\/rtph.2000.1421_RF38","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1006\/rtph.1996.0055","article-title":"Low digestible carbohydrates (polyols and lactose): Significance of adrenal medullary proliferative lesions in the rat","volume":"23","author":"Lynch","year":"1996","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1006\/rtph.2000.1421_RF39","series-title":"U.S. Physicians Desk Reference (PDR)","year":"1996"},{"key":"10.1006\/rtph.2000.1421_RF40","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/toxsci\/52.1.101","volume":"52","author":"Mordenti","year":"1999","journal-title":"Toxicol. Sci."},{"key":"10.1006\/rtph.2000.1421_RF41","series-title":"Encyclopedia of Pharmaceutical Technology","first-page":"49","article-title":"Complexation and cyclodextrins","author":"Mosher","year":"2000"},{"key":"10.1006\/rtph.2000.1421_RF42","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0278-6915(98)00091-X","article-title":"Erythritol: An interpretive summary of biochemical, metabolic, toxicological and clinical data","volume":"36","author":"Munro","year":"1998","journal-title":"Food Chem. Toxicol."},{"key":"10.1006\/rtph.2000.1421_RF43","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3181\/00379727-76-18626","article-title":"Pathological changes in rabbits from repeated intravenous injections of Periston (polyvinyl pyrrolidone) or dextran","volume":"76","author":"Nelson","year":"1951","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1006\/rtph.2000.1421_RF44","series-title":"Encyclopedia of Pharmaceutical Technology","first-page":"137","article-title":"Excipients: Their role in parenteral dosage forms","author":"Nema","year":"2000"},{"key":"10.1006\/rtph.2000.1421_RF45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/biol.1998.0169","article-title":"Design of a \u201cmicrobicide\u201d for prevention of sexually transmitted diseases using \u201cinactive\u201d pharmaceutical excipients","volume":"27","author":"Neurath","year":"1999","journal-title":"Biologicals"},{"key":"10.1006\/rtph.2000.1421_RF46","series-title":"The Rules Governing Medicinal Products in the European Union","year":"1998"},{"key":"10.1006\/rtph.2000.1421_RF47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0278-6915(99)00116-7","article-title":"Developmental toxicity study of Aquacoat ECD ethylcellulose aqueous dispersion administered orally to rats","volume":"38","author":"Palmieri","year":"2000","journal-title":"Food Chem. Toxicol."},{"key":"10.1006\/rtph.2000.1421_RF48","series-title":"Martindale: The Complete Drug Reference","year":"1999"},{"key":"10.1006\/rtph.2000.1421_RF49","first-page":"132","article-title":"Evaluation of the effect of polyethylene glycol 400 on the nasal absorption of nicardipine and verapamil in the rat","volume":"54","author":"Rahman","year":"1999","journal-title":"Pharmazie"},{"key":"10.1006\/rtph.2000.1421_RF50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000246039","article-title":"Povidone-iodine liposomes\u2014An overview","volume":"195","author":"Reimer","year":"1997","journal-title":"Dermatology"},{"key":"10.1006\/rtph.2000.1421_RF51","series-title":"The Dictionary of Substances and their Effects","author":"Richardson","year":"1992"},{"key":"10.1006\/rtph.2000.1421_RF52","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0378-5173(99)00110-6","article-title":"Regulatory issues with excipients","volume":"187","author":"Robertson","year":"1999","journal-title":"Int. J. Pharmacol."},{"key":"10.1006\/rtph.2000.1421_RF53","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/096032718900800202","article-title":"Relevance for man of the effects of lactose, polyols and other carbohydrates on calcium metabolism seen in rats: A review","volume":"8","author":"Roe","year":"1989","journal-title":"Hum. Toxicol."},{"key":"10.1006\/rtph.2000.1421_RF54","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0005-2736(99)00139-X","article-title":"Localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue: Influence of liposome characteristics","volume":"1421","author":"Schiffelers","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1006\/rtph.2000.1421_RF55","first-page":"22","article-title":"Developments in tablet excipients since 1960","volume":"December","author":"Shangraw","year":"1986","journal-title":"Manufact. Chem."},{"key":"10.1006\/rtph.2000.1421_RF56","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0300-483X(78)90009-4","article-title":"The sensitisation potential of some perfume ingredients tested using a modified Draize procedure","volume":"9","author":"Sharp","year":"1978","journal-title":"Toxicology"},{"key":"10.1006\/rtph.2000.1421_RF57","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1006\/rtph.1996.0120","article-title":"A new approach to the safety assessment of pharmaceutical excipients","volume":"24","author":"Steinberg","year":"1996","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1006\/rtph.2000.1421_RF58","first-page":"1388","article-title":"Poly (lactic\/glycolic acid) microspheres containing antigen as a novel and potential agent of immunotherapy for allergic disorders","volume":"41","author":"Takagi","year":"1992","journal-title":"Arerugi"},{"key":"10.1006\/rtph.2000.1421_RF59","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1023\/A:1011922819926","article-title":"Stealth PLA-PEG nanoparticles as protein carriers for nasal administration","volume":"15","author":"Tobio","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1006\/rtph.2000.1421_RF60","first-page":"1","article-title":"Cyclodextrins-enabling excipients: Their present and future use in pharmaceuticals in drug formulations","volume":"14","author":"Thompson","year":"1997","journal-title":"Crit. Rev. Ther. Drug Carrier Sys."},{"key":"10.1006\/rtph.2000.1421_RF61","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/immu.1994.1027","article-title":"Immunoliposomes and PEGylated immunoliposomes: Possible use for targeted delivery of imaging agents","volume":"4","author":"Torchilin","year":"1994","journal-title":"Immunomethods"},{"key":"10.1006\/rtph.2000.1421_RF62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/009286159903300104","article-title":"Regulatory status of excipients in Japan","volume":"33","author":"Uchiyama","year":"1999","journal-title":"Drug Inform. J."},{"key":"10.1006\/rtph.2000.1421_RF63","first-page":"302","article-title":"Teratogenic effects of polyethylene glycol 200 in the mouse but not in the rat","volume":"40","author":"Vannier","year":"1989","journal-title":"Teratology"},{"key":"10.1006\/rtph.2000.1421_RF64","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4615-1823-5_7","article-title":"A compendium of vaccine adjuvant and excipients","volume":"6","author":"Vogel","year":"1995","journal-title":"Pharm. Biotechnol."},{"key":"10.1006\/rtph.2000.1421_RF65","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3109\/10408449309104076","article-title":"Toxicologic testing of inhaled pharmaceutical aerosols","volume":"23","author":"Wolff","year":"1993","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1006\/rtph.2000.1421_RF66","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0163-7258(96)00069-1","article-title":"Saccharin mechanistic data and risk assessment: Urine composition, enhanced cell proliferation, and tumour promotion","volume":"71","author":"Wysner","year":"1996","journal-title":"Pharmacol. Ther."},{"key":"10.1006\/rtph.2000.1421_RF67","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1177\/019262339902700406","article-title":"Contrast medium- and mannitol-induced apoptosis in heart and kidney of SHR rats","volume":"27","author":"Zhang","year":"1999","journal-title":"Toxicol. Pathol."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230000914211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230000914211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T16:44:33Z","timestamp":1680540273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230000914211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["S0273230000914211"],"URL":"https:\/\/doi.org\/10.1006\/rtph.2000.1421","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2000,10]]}}}